documents: FDA-2022-D-0084-0021

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2022-D-0084-0021 FDA FDA-2022-D-0084 Use of Circulating Tumor Deoxyribonucleic Acid for Curative- Intent Solid Tumor Drug Development; Guidance for Industry; Availability Notice Notice of Availability 2024-11-29T05:00:00Z 2024 11 2024-11-29T05:00:00Z   2024-11-29T15:07:39Z 2024-28033 0 0 090000648683f00a

Links from other tables